Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2007
12/13/2007WO2007008220A3 Gene or drug delivery system
12/13/2007WO2006127990A3 Thrombin purification
12/13/2007WO2006123256A8 Hivcon: an hiv immunogen and uses thereof
12/13/2007WO2006122327A3 Milk fat globule epidermal growth factor-factor viii and sepsis
12/13/2007WO2006107751A3 Combined therapy utilizing reduction of dna methyltansferase expression and/or activity and interferon
12/13/2007WO2006076255A3 Method of treating or preventing microbial eye infection
12/13/2007WO2005113019A3 Methods for the treatment of autoimmune diseases
12/13/2007WO2005086751A3 Combinatorial interleukin-2 muteins
12/13/2007WO2005039505A3 Compositions and methods for healthy pregnancy
12/13/2007WO2005017103A3 Bacterial nitric oxide synthases and uses thereof
12/13/2007WO2004015390A3 Lung cancer target proteins and use thereof
12/13/2007WO2003101600A3 Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous-aqueous emulsion
12/13/2007WO2003017923A3 Anticancer polypeptide-metal complexes and compositions, methods of making, and methods of using same
12/13/2007WO2001083684A3 A novel polypeptide, a human zinc-finger krab kraz2-13 protein and the polynucleotide encoding the polypeptide
12/13/2007WO2001075035A3 A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide
12/13/2007US20070287949 Transdermal System for Sustained Delivery of Polypeptides
12/13/2007US20070287826 Production of high molecular mass lectins
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287677 Rad51 Expression Inhibitors, Pharmaceutical Agents Containing The Inhibitors As Active Ingredients, And Uses Thereof
12/13/2007US20070287672 Macromolecular Gsh-Activiated Glyoxylase I Inhibitors
12/13/2007US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis
12/13/2007US20070287670 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions
12/13/2007US20070287669 Combined Use of Derivatives of GLP-1 Analogs and PPAR Ligands
12/13/2007US20070287668 Methods, kits, and antibodies for detecting parathyroid hormone
12/13/2007US20070287667 Chimpanzee monoclonal antibodies and antigen binding fragments including variable region peptides; bioassay for detection of hepatitis A virus; diagnosis, treatment and prevention of hepatitis; kits
12/13/2007US20070287666 Modulator of gamma-secretase
12/13/2007US20070287665 Urotensin-II agonists and antagonists
12/13/2007US20070287664 Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto
12/13/2007US20070287663 Glycopeptide Composition with Improved Antibiotic Activity
12/13/2007US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
12/13/2007US20070287661 Compositions and methods for prevention or treatment of thrombocytopenia and methods for manufacturing said compositions
12/13/2007US20070287660 Chimeric metalloenzyme comprising fibrin binding domain for for use in treatment and prevention of thrombosis and cardiovascular disorders
12/13/2007US20070287177 Bonding to monoclonal antibodies; antitumor agents
12/13/2007US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007US20070286906 Dihydrobenzoquinone compounds
12/13/2007US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome
12/13/2007US20070286885 Elastin-based copolymers
12/13/2007US20070286882 Solvent systems for coating medical devices
12/13/2007US20070286881 Method, composition and kit for treating degenerated disc disease and discogenic pain
12/13/2007US20070286870 Modified Vp1-Capsid Protein Of Parvovirus B19
12/13/2007US20070286866 Compositions For Reducing Bacterial Carriage And Cnc Invasion And Methods Of Using Same
12/13/2007US20070286863 CMKLR regulation of adipogenesis and adipocyte metabolic function
12/13/2007US20070286862 Cancer Associated Antigens
12/13/2007US20070286854 Diagnostics And Therapeutics For Diseases Associated With Dipeptidyl-Peptidase 1 (Dpp1)
12/13/2007US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
12/13/2007US20070286851 Method of Identifying Modulators of NOGO-Functions
12/13/2007US20070286850 Mevalonate Kinase
12/13/2007US20070286848 Epas1 Gene Transfer to Improve Cell Therapy
12/13/2007US20070286846 Novel methods for ester detoxication
12/13/2007US20070286843 Recombinant Polypeptides of the Members of the Tnf Ligand Family and Use Thereof
12/13/2007US20070286842 serine protease inhibitors, for the treatment of hepatitis c virus infections
12/13/2007US20070286807 Method Of Inducing Or Modulating Immune Response
12/13/2007US20070286806 Methods and Compositions for Modulating a Steroid Receptor
12/13/2007US20070286803 Compositions and methods for detecting and treating tumors containing acidic areas
12/13/2007DE102006027450A1 Verfahren zur Induktion der Insulinsynthese in Chorionzellen A method for inducing the synthesis of insulin in chorion
12/13/2007CA2687890A1 Isolated milk or whey cationic fraction for treating a microbial infection
12/13/2007CA2665034A1 Methods for treating a urethral stricture with a botulinum toxin
12/13/2007CA2657971A1 Vaccine carrier
12/13/2007CA2657947A1 Fkbp-l and uses thereof
12/13/2007CA2657946A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease
12/13/2007CA2655273A1 Combination of somatostatin-analogs with dopamine- or growth hormone receptor antagonist
12/13/2007CA2654761A1 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
12/13/2007CA2654330A1 Monoclonal anti-annexin a3 antibodies for the detection of prostate carcinoma
12/13/2007CA2654304A1 Compositions and methods for modulating vascular development
12/13/2007CA2654181A1 Use of proteins and peptides of the tgf-beta superfamily for purification and therapeutic methods
12/13/2007CA2654154A1 Treatment of ischemic diseases using erythropoietin
12/13/2007CA2654020A1 Methods for inhibiting cardiac pai-1
12/13/2007CA2653781A1 Stabilized insulin-like growth factor polypeptides
12/13/2007CA2653537A1 Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
12/13/2007CA2652989A1 Derivatized insulin oligomers
12/13/2007CA2652620A1 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof
12/13/2007CA2652549A1 Use of a soluble morphogenic protein complex for treating cartilage defects
12/13/2007CA2650230A1 Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions
12/13/2007CA2650133A1 Aminothiazole derivatives and their uses as antibacterial agents
12/13/2007CA2628116A1 Compositions and methods for diagnosing and treating cancer
12/13/2007CA2626082A1 Methods and compositions for use in treatment of patients with autoantibody positive disease
12/12/2007EP1865065A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
12/12/2007EP1865061A2 IL-17 homologous polypeptides and therapeutic uses thereof
12/12/2007EP1865055A1 Component of bromelain
12/12/2007EP1864996A1 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.
12/12/2007EP1864994A1 Par-2 agonist
12/12/2007EP1864981A1 Thrombopoietin mimetics
12/12/2007EP1864692A1 Use of peptides for the control of radiation injury
12/12/2007EP1864681A1 Growth factor modified protein matrices for tissue engineering
12/12/2007EP1864678A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene
12/12/2007EP1864677A1 Stable formulation comprising a moisture sensitive drug and manufacturing procedure thereof
12/12/2007EP1864676A1 Antigenic modification of polypeptides
12/12/2007EP1864675A1 Orally administered peptides to ameliorate atherosclerosis
12/12/2007EP1864661A1 Prophylactic/therapeutic agent for stress-induced bowel disease
12/12/2007EP1864131A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof
12/12/2007EP1863926A2 Compositions and methods for treating inflammatory cns disorders
12/12/2007EP1863910A1 Targeted plasminogen activator fusion proteins as thrombolytic agents
12/12/2007EP1863848A2 Antibodies and related molecules that bind to 161p2f10b proteins
12/12/2007EP1863842A2 High affinity hiv t cell receptors
12/12/2007EP1863841A1 Compounds for use in the treatment of obesity
12/12/2007EP1863839A2 Acylated glp-1 compounds
12/12/2007EP1863838A1 Statherin peptide and use in medicine
12/12/2007EP1863832A1 Age inhibitors
12/12/2007EP1863573A1 Treatment of laminitis
12/12/2007EP1863537A2 Dimeric peptide agonists of the glp-1 receptor
1 ... 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 ... 3163